A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease

Show full item record



Permalink

http://hdl.handle.net/10138/315924

Citation

Emdin , C A , Haas , M E , Khera , A V , Aragam , K , Chaffin , M , Klarin , D , Hindy , G , Jiang , L , Wei , W-Q , Feng , Q , Karjalainen , J , Havulinna , A , Kiiskinen , T , Bick , A , Ardissino , D , Wilson , J G , Schunkert , H , McPherson , R , Watkins , H , Elosua , R , Bown , M J , Samani , N J , Baber , U , Erdmann , J , Gupta , N , Danesh , J , Saleheen , D , Chang , K-M , Vujkovic , M , Voight , B , Damrauer , S , Lynch , J , Kaplan , D , Serper , M , Tsao , P , Program , M V , Mercader , J , Hanis , C , Daly , M , Denny , J , Gabriel , S & Kathiresan , S 2020 , ' A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease ' , PLoS Genetics , vol. 16 , no. 4 , 1008629 . https://doi.org/10.1371/journal.pgen.1008629

Title: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
Author: Emdin, Connor A.; Haas, Mary E.; Khera, Amit V.; Aragam, Krishna; Chaffin, Mark; Klarin, Derek; Hindy, George; Jiang, Lan; Wei, Wei-Qi; Feng, Qiping; Karjalainen, Juha; Havulinna, Aki; Kiiskinen, Tuomo; Bick, Alexander; Ardissino, Diego; Wilson, James G.; Schunkert, Heribert; McPherson, Ruth; Watkins, Hugh; Elosua, Roberto; Bown, Matthew J.; Samani, Nilesh J.; Baber, Usman; Erdmann, Jeanette; Gupta, Namrata; Danesh, John; Saleheen, Danish; Chang, Kyong-Mi; Vujkovic, Marijana; Voight, Ben; Damrauer, Scott; Lynch, Julie; Kaplan, David; Serper, Marina; Tsao, Philip; Program, Million Veteran; Mercader, Josep; Hanis, Craig; Daly, Mark; Denny, Joshua; Gabriel, Stacey; Kathiresan, Sekar
Contributor: University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Complex Disease Genetics
University of Helsinki, Institute for Molecular Medicine Finland
Date: 2020-04-13
Language: eng
Number of pages: 16
Belongs to series: PLoS Genetics
ISSN: 1553-7390
URI: http://hdl.handle.net/10138/315924
Abstract: Author summary Cirrhosis is a leading cause of death worldwide. However, the genetic underpinnings of cirrhosis remain poorly understood. In this study, we analyze twelve thousand individuals with cirrhosis and identify a common missense variant in a gene called MARC1 that protects against cirrhosis. Carriers of this missense variant also have lower blood cholesterol levels, lower liver enzyme levels and reduced liver fat. We identify an additional two low-frequency coding variants in MARC1 that are also associated with lower cholesterol levels, lower liver enzyme levels and protection from cirrhosis. Finally, we identify an individual homozygous for a predicted loss-of-function variant in MARC1 who exhibits very low blood LDL cholesterol levels. These genetic findings suggest that MARC1 deficiency may lower blood cholesterol levels and protect against cirrhosis, pointing to MARC1 as a potential therapeutic target for liver disease. Analyzing 12,361 all-cause cirrhosis cases and 790,095 controls from eight cohorts, we identify a common missense variant in the Mitochondrial Amidoxime Reducing Component 1 gene (MARC1 p.A165T) that associates with protection from all-cause cirrhosis (OR 0.91, p = 2.3*10(-11)). This same variant also associates with lower levels of hepatic fat on computed tomographic imaging and lower odds of physician-diagnosed fatty liver as well as lower blood levels of alanine transaminase (-0.025 SD, 3.7*10(-43)), alkaline phosphatase (-0.025 SD, 1.2*10(-37)), total cholesterol (-0.030 SD, p = 1.9*10(-36)) and LDL cholesterol (-0.027 SD, p = 5.1*10(-30)) levels. We identified a series of additional MARC1 alleles (low-frequency missense p.M187K and rare protein-truncating p.R200Ter) that also associated with lower cholesterol levels, liver enzyme levels and reduced risk of cirrhosis (0 cirrhosis cases for 238 R200Ter carriers versus 17,046 cases of cirrhosis among 759,027 non-carriers, p = 0.04) suggesting that deficiency of the MARC1 enzyme may lower blood cholesterol levels and protect against cirrhosis.
Subject: 3111 Biomedicine
GENOME-WIDE ASSOCIATION
CONFERS SUSCEPTIBILITY
RISK LOCI
PNPLA3
MORTALITY
ANGPTL3
ENZYMES
PROTEIN
TM6SF2
YIELD
1184 Genetics, developmental biology, physiology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
journal.pgen.1008629.pdf 1.118Mb PDF View/Open
journal.pgen.1008629.pdf 1.673Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record